Orexo AB Financials
| ORXOF Stock | USD 1.08 0.00 0.00% |
With this module, you can analyze Orexo financials for your investing period. You should be able to track the changes in Orexo AB individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Orexo |
Understanding current and past Orexo AB Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Orexo AB's financial statements are interrelated, with each one affecting the others. For example, an increase in Orexo AB's assets may result in an increase in income on the income statement.
The data published in Orexo AB's official financial statements typically reflect Orexo AB's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Orexo AB's quantitative information. For example, before you start analyzing numbers published by Orexo accountants, it's essential to understand Orexo AB's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Orexo AB Stock Summary
Orexo AB competes with Genomma Lab, Hypera SA, Elanco Animal, SIGA Technologies, and Esperion Therapeutics. Orexo AB , a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Orexo AB was incorporated in 1994 and is headquartered in Uppsala, Sweden. Orexo Ab is traded on OTC Exchange in the United States.| Instrument | USA OTC Stock View All |
| Exchange | OTCQX Exchange |
| Business Address | PO Box 303, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.orexo.com |
| Phone | 46 1 87 80 88 00 |
| Currency | USD - US Dollar |
Orexo AB Key Financial Ratios
There are many critical financial ratios that Orexo AB's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Orexo AB reports annually and quarterly.| Return On Equity | -0.65 | |||
| Return On Asset | -0.0965 | |||
| Number Of Employees | 126 | |||
| Beta | 0.72 |
Orexo Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Orexo AB's current stock value. Our valuation model uses many indicators to compare Orexo AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Orexo AB competition to find correlations between indicators driving Orexo AB's intrinsic value. More Info.Orexo AB is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Orexo AB's earnings, one of the primary drivers of an investment's value.Orexo AB Systematic Risk
Orexo AB's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Orexo AB volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Orexo AB correlated with the market. If Beta is less than 0 Orexo AB generally moves in the opposite direction as compared to the market. If Orexo AB Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Orexo AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Orexo AB is generally in the same direction as the market. If Beta > 1 Orexo AB moves generally in the same direction as, but more than the movement of the benchmark.
Orexo AB November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Orexo AB help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Orexo AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Orexo AB based on widely used predictive technical indicators. In general, we focus on analyzing Orexo OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Orexo AB's daily price indicators and compare them against related drivers.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 28.0 |
Complementary Tools for Orexo OTC Stock analysis
When running Orexo AB's price analysis, check to measure Orexo AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orexo AB is operating at the current time. Most of Orexo AB's value examination focuses on studying past and present price action to predict the probability of Orexo AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orexo AB's price. Additionally, you may evaluate how the addition of Orexo AB to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |